Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Pharmacyclics
Pharmacyclics
A Developing "Breakthrough" In Biotechnology that You Should Monitor
Motley Fool
Sat, 07/13/13 - 12:31 pm
Pharmacyclics
ibrutinib
blood cancer
JNJ
AbbVie
Cellceutix And Kevetrin Aligning With The Pharmacyclics Growth Curve
Seeking Alpha
Thu, 07/11/13 - 12:06 pm
Cellceutix
Kevetrin
Pharmacyclics
Will This Be the Breakthrough of All Breakthrough Therapy Drugs?
Motley Fool
Thu, 07/11/13 - 11:09 am
breakthrough therapies
ibrutinib
Pharmacyclics
JNJ
chronic lymphocytic leukemia
Pharmacyclics and Johnson & Johnson submit blood cancer drug ibrutinib to FDA for approval
Yahoo/AP
Wed, 07/10/13 - 11:05 am
JNJ
Pharmacyclics
ibrutinib
chronic lymphocytic leukemia
[video]3 Blood Cancer Drug Hopefuls in the Spotlight
Motley Fool
Thu, 06/20/13 - 07:46 am
Infinity Pharmaceuticals
JNJ
Pharmacyclics
Gilead
non-Hodgkin's lymphoma
ibrutinib
Idelalisib
IPI-145
When It Comes To Biotech, Diversity Is Key
Seeking Alpha
Wed, 06/12/13 - 09:03 am
biotech
Alkermes
Celgene
AstraZeneca
Coronado Biosciences
Dendreon
Incyte
Isis Pharmaceuticals
JNJ
Eli Lilly
Merck
Novavax
Novartis
Pfizer
Sangamo BioSciences
Pharmacyclics
Making The Call: Pharmacyclics FDA Drug Approval Before Year End
TheStreet.com
Wed, 05/29/13 - 08:18 am
FDA
Pharmacyclics
JNJ
ibrutinib
B-cell cancers
Gilead Sciences' Move Into Cancer Drugs
Seeking Alpha
Mon, 05/27/13 - 09:50 am
Gilead
Pharmacyclics
blood cancer
leukemia
Tackling Cancer: Leukemia's Biggest Current and Upcoming Players
Motley Fool
Mon, 05/20/13 - 11:40 am
leukemia
Sprycel
Bristol-Myers Squibb
Gleevec
Novartis
Iclusig
Ariad Pharmaceuticals
Bosulif
Pfizer
Erwinaze
Jazz Pharmaceuticals
Idelalisib
Gilead
ibrutinib
Pharmacyclics
ASCO '13 Preview: Gilead's Big Cancer Debut
TheStreet.com
Thu, 05/16/13 - 08:54 am
Gilead
ASCO
JNJ
Pharmacyclics
idelalisab
ibrutinib
CLL
Cellceutix Corporation: The Next Generation Of Cancer Treatment Has Arrived
Seeking Alpha
Fri, 05/10/13 - 08:31 am
Cellceutix
AstraZeneca
GSK
Celgene
Eli Lilly
Roche
Pfizer
Pharmacyclics
Kevetrin
cancer
Biotech Watchlist 2013 Update: Exciting Ideas Have Explosive Potential
Seeking Alpha
Sat, 05/4/13 - 10:32 am
Vertex Pharmaceuticals
Pharmacyclics
Novartis
Celsion
Peregrine Pharmaceuticals
Prana
Navidea Biopharmaceuticals
Cardinal Health
ONYX Pharmaceuticals
Bayer
Sarepta
Hyperion Therapeutics
Amarin
Medivation
Astellas
JNJ
Trius
Sangamo BioSciences
Pharmacyclics says FDA grants Breakthrough Therapy Designation for ibrutinib
Yahoo/Fly on the Wall
Mon, 04/8/13 - 11:05 am
FDA
Pharmacyclics
ibrutinib
CLL
The Wild Story Behind A Promising Experimental Cancer Drug
Forbes
Sat, 04/6/13 - 11:04 am
ibrutinib
Pharmacyclics
chronic lymphocytic leukemia
mantle cell lymphoma
JNJ
The Best- And Worst-Performing Biotech Stocks In February
Forbes
Mon, 03/4/13 - 10:55 am
Optimer
Questcor
Celldex
OraSure
Pharmacyclics
Taro
Synta Pharmaceuticals
Keryx
Dynavax
Affymax
Tackling Cancer: The Current and Upcoming Players
Motley Fool
Wed, 02/27/13 - 11:36 am
Life Technologies
JNJ
Pharmacyclics
Pharmacyclics Valuation Jumps Over $1 Billion On Newest Developments
Seeking Alpha
Wed, 02/20/13 - 11:48 am
Pharmacyclics
JNJ
Pharmacyclics Still on a Roll After Earnings Results
Motley Fool
Mon, 02/18/13 - 12:00 pm
Pharmacyclics
earnings
Pharmacyclics jumps on drug approval plans
Yahoo/AP
Sat, 02/16/13 - 11:59 am
Pharmacyclics
ibrutinib
mantle cell lymphoma
3 Humongous Health-Care Stocks This Week
Motley Fool
Sat, 02/16/13 - 11:35 am
JNJ
Pharmacyclics
Herbalife
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
next ›
last »